[HTML][HTML] Gender differences in autoimmune disease

ST Ngo, FJ Steyn, PA McCombe - Frontiers in neuroendocrinology, 2014 - Elsevier
Autoimmune diseases are a range of diseases in which the immune response to self-
antigens results in damage or dysfunction of tissues. Autoimmune diseases can be systemic …

Autoimmune disease in women: endocrine transition and risk across the lifespan

MK Desai, RD Brinton - Frontiers in endocrinology, 2019 - frontiersin.org
Women have a higher incidence and prevalence of autoimmune diseases than men, and
85% or more patients of multiple autoimmune diseases are female. Women undergo …

[HTML][HTML] Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis

T Chitnis, DL Arnold, B Banwell, W Brück… - … England Journal of …, 2018 - Mass Medical Soc
Background Treatment of patients younger than 18 years of age with multiple sclerosis has
not been adequately examined in randomized trials. We compared fingolimod with …

Pediatric multiple sclerosis: a review

R Alroughani, A Boyko - BMC neurology, 2018 - Springer
Background Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are
increasing globally. No disease-modifying therapy are approved for MS pediatric population …

Natural history of multiple sclerosis with childhood onset

C Renoux, S Vukusic, Y Mikaeloff, G Edan… - … England Journal of …, 2007 - Mass Medical Soc
Background The course and prognosis of childhood-onset multiple sclerosis have not been
well described. Methods We used data from 13 adult neurology departments affiliated with …

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

RC Dale, C De Sousa, WK Chong, TCS Cox, B Harding… - Brain, 2000 - academic.oup.com
Forty-eight children with disseminated demyelination of the CNS, 28 with acute
disseminated encephalomyelitis (ADEM), seven with multiphasic disseminated …

Early onset multiple sclerosis: a longitudinal study

A Boiko, G Vorobeychik, D Paty, V Devonshire… - Neurology, 2002 - AAN Enterprises
Objective: To evaluate the clinical course of MS in individuals with onset of MS before age
16. Methods: Patients with onset of MS before age 16 (n= 116) with complete clinical …

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study

B Banwell, A Bar-Or, DL Arnold, D Sadovnick… - The Lancet …, 2011 - thelancet.com
Summary Background HLA-DRB1* 15 genotype, previous infection with Epstein-Barr virus,
and vitamin D insufficiency are susceptibility factors for multiple sclerosis, but whether they …

Incidence of acquired demyelination of the CNS in Canadian children

B Banwell, J Kennedy, D Sadovnick, DL Arnold… - Neurology, 2009 - AAN Enterprises
Background: The incidence of acquired demyelination of the CNS (acquired demyelinating
syndromes [ADS]) in children is unknown. It is important that physicians recognize the …

Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions

B Banwell, A Ghezzi, A Bar-Or, Y Mikaeloff… - The Lancet …, 2007 - thelancet.com
The onset of multiple sclerosis (MS) in childhood poses diagnostic and therapeutic
challenges, particularly if the symptoms of the first demyelinating event resemble acute …